Biocure Technology Inc (TSE:CURE.X)
CNQX:CURE.X
Holding TSE:CURE.X?
Track your performance easily

Biocure Technology Inc (CURE.X) Cash flow

4 Followers

Biocure Technology Inc Cash Flow

TSE:CURE.X's free cash flow for Q4 2023 was C$-705.00. For the 2023 fiscal year, TSE:CURE.X's free cash flow was decreased by C$608.80K and operating cash flow was C$-705.00. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
C$ 28.94KC$ -217.13KC$ -825.92KC$ -1.08MC$ -1.31MC$ -2.68M
Investing Cash Flow
C$ 19.94KC$ 43.31KC$ 74.80KC$ -3.94KC$ 91.49KC$ -1.05M
Financing Cash Flow
C$ -56.04KC$ 140.38KC$ 630.93KC$ 1.17MC$ 1.13MC$ 3.69M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
C$ -109.87KC$ -30.95KC$ 38.51KC$ 159.10KC$ 46.68KC$ 132.44K
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
---C$ 1.10MC$ 985.38KC$ 1.76M
Issuance Of Debt
C$ -47.00KC$ -47.00K-C$ 70.53KC$ 148.58KC$ 1.93M
Repayment Of Debt
C$ -47.00KC$ -47.00K-C$ -102.02KC$ -253.00KC$ -59.39K
Free Cash Flow
C$ 28.94KC$ -217.13KC$ -825.92KC$ -1.08MC$ -1.31MC$ -2.68M
Domestic Sales
------
Foreign Sales
------
Currency in CAD

Biocure Technology Inc Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis